Where does ResMed Pty Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ResMed Pty Ltd ranks #565 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ResMed Pty Ltd hold?

ResMed Pty Ltd holds 800 US utility patents granted between 2019 and 2025, spanning 62 technology areas.

What is ResMed Pty Ltd's Innovation Score?

ResMed Pty Ltd has an Innovation Score of 70.2 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ResMed Pty Ltd's patent grant rate increasing or decreasing?

ResMed Pty Ltd's recent grant velocity is +993% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for ResMed Pty Ltd's patents?

ResMed Pty Ltd's patents average 22.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ResMed Pty Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

ResMed Pty Ltd

Q: What technology areas does ResMed Pty Ltd focus on?

ResMed Pty Ltd's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 682 patents. Grants appear in 62 CPC subclasses total.

USPTO PatentsView assignee record - 800 granted patents across 62 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Resmed ranks #565 of 49,997 tracked US assignees by granted-patent volume, with 800 patents across 62 technology areas.

#565
of 49,997 US assignees by volume: Top 1%
by Innovation Score (70.2/100): 22.5
avg claims per patent: +993%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R565 · Foreign Corporation #565 · 800 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 800 grants
TOP-DECILE #565/49,997
PHOTO-FINISH B/E Aerospace
CPC-WIDE A61M · 62 areas
INNOV-STRONG 70.2/100
CLAIMS-DENSE 22.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +993% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: B/E Aerospace, Inc. (±1 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
CreateMe · near

70
Sony Interactive… · near

70
ResMed Pty · this assignee

70
PETRÓLEO Brasileiro… · near

70
Igus · near

70
3D Lighting… · lowest

7

What this shows Resmed's Innovation Score is 70.2/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Resmed's grant cadence moved

Between 2020–2024, ResMed Pty Ltd received 656 grants versus 60 in 2015–2019 (+993% equal-window velocity, top decile growth). Across complete PatentsView years, output peaked in 2022 at 161 grants and bottomed in 2019 at 60. Lead class A61M accounts for 85.3% of the portfolio across 62 subclasses. Volume neighbours: Ut-battelle, LLC (#561) and Gentex Corporation (#569).

Resmed's three-year grant acceleration

From 2019–2021 to 2022–2024, ResMed Pty Ltd moved from 313 to 403 grants (1.29x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #658. See the growth leaderboard.

Ut-battelle

803
Hefei BOE Optoele…

802
B/E Aerospace

801
Fortinet

801
Resmed Pty ◀

800
Wipro

794
Alcon

793
Bally Gaming

792
Gentex

790

What this shows ResMed holds 800 patents at rank #565, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ResMed

By rank, the assignees closest to #565 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in ResMed's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ResMed, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (70 here).

Sony Interactive Entertainment Inc. 70 PETRÓLEO Brasileiro S.A.—PETROBRAS 70 CreateMe Technologies Inc. 70 Igus GMBH 70

Similar claim depth

Nearest assignees by average claims per patent (22.5 here).

Time Warner Cable Enterprises LLC 22.5 avg Avery Dennison Corporation 22.5 avg Mbit Wireless, Inc. 22.5 avg Sion Power Corporation 22.5 avg

Resmed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

70 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

ResMed Pty Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	60	7.5%
2020	131	16.4%
2021	122	15.3%
2022	161	20.1%
2023	130	16.3%
2024	112	14.0%
2025partial year	84	10.5%

Which technologies does ResMed Pty Ltd patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 682

A61B - DIAGNOSIS; SURGERY; Identification 99

A62B - Devices, Apparatus OR Methods FOR Life-saving 59

Y10T - Technical Subjects Covered BY Former US Classification 37

Y02A - Technologies FOR Adaptation TO Climate Change 34

F04D - Non-positive-displacement Pumps 33

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 28

H05B - Electric HEATING; Electric Light Sources NOT Otherwise Provided FOR; Circuit Arrangements FOR Electric Light Sources, IN General 22

G06F - Electric Digital Data Processing 18

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 15

F24F - AIR-CONDITIONING; AIR-HUMIDIFICATION; VENTILATION; USE OF AIR Currents FOR Screening 15

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 12

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 12

D10B - Indexing Scheme Associated With Sublasses OF Section D, Relating TO Textiles 11

G02B - Optical Elements, Systems OR Apparatus 10

Top 15 of 62 technology areas

Where it ranks

Overall rank by patents

#565

of 49,997 tracked assignees

Innovation Score

70.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

ResMed Pty Ltd's patent record in context - here's where to go next.

ResMed Pty Ltd's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 85.3% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #565 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ResMed Pty Ltd against Ut-battelle, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 70.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.